(Q40578925)

21 September 2017

1 reference

title

Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment (English)

1 reference

21 September 2017

J A Roth

1

1 reference

21 September 2017

1 January 1994

1 reference

Annals of Surgical Oncology

21 September 2017

1 reference

21 September 2017

1

1 reference

21 September 2017

1

1 reference

21 September 2017

79-86

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02303545

21 September 2017

0 references

cites work

Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02303545

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02303545

p53 Gene Mutations in Esophageal Cancer Detected by Polymerase Chain Reaction Single-strand Conformation Polymorphism Analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02303545

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

12 December 2020

Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.

1 reference

12 December 2020

Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

1 reference

12 December 2020

Adenocarcinoma and Barrett's esophagus. An overrated risk?

1 reference

12 December 2020

Genetic mechanisms of tumor suppression by the human p53 gene

1 reference

12 December 2020

A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53.

1 reference

12 December 2020

The p53 tumour suppressor gene

1 reference

12 December 2020

Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

1 reference

12 December 2020

Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct

1 reference

12 December 2020

Tumor suppressor genes

1 reference

12 December 2020

Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

1 reference

12 December 2020

Sequence-specific interaction of a conformational domain of p53 with DNA.

1 reference

12 December 2020

Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction

1 reference

12 December 2020

Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.

1 reference

12 December 2020

High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors

1 reference

12 December 2020

Mutations in the p53 gene occur in diverse human tumour types

1 reference

12 December 2020

17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma

1 reference

12 December 2020

From gene to carcinogen: a rapidly evolving field in molecular epidemiology

1 reference

12 December 2020

p53 gene mutations in Barrett's epithelium and esophageal cancer

1 reference

12 December 2020

Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions

1 reference

12 December 2020

p53 mutations in human cancers

1 reference

12 December 2020

Molecular themes in oncogenesis

1 reference

12 December 2020

Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma

1 reference

12 December 2020

An adenovirus vector for gene transfer into neurons and glia in the brain

1 reference

12 December 2020

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

12 December 2020

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

1 reference

12 December 2020

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

12 December 2020

ras oncogenes in human cancer: a review

1 reference

12 December 2020

p53: oncogene or anti-oncogene?

1 reference

12 December 2020

Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations

1 reference

12 December 2020

Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract

1 reference

12 December 2020

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

1 reference

12 December 2020

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1

1 reference

12 December 2020

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

12 December 2020

Frequent mutation of the p53 gene in human esophageal cancer

1 reference

12 December 2020

The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

1 reference

12 December 2020

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02303545

1 reference

PubMed ID

7834433

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7834433